Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuya Inoue

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Iscience|March 19, 2024
Overcoming antibody-resistant SARS-CoV-2 variants with bispecific antibodies constructed using non-neutralizing antibodiesTetsuya Inoue, Yuichiro Yamamoto, Kaoru Sato, et al.
EJNMMI Research|December 6, 2019
Combination of FDG-PET and FMISO-PET as a treatment strategy for patients undergoing early-stage NSCLC stereotactic radiotherapyShiro Watanabe, Tetsuya Inoue, Shozo Okamoto, et al.
Journal of Radiation Research|May 14, 2026
Optimal combination of heart and lung dose parameters in radiotherapy for locally advanced non-small cell lung carcinoma: a multicenter retrospective studyTomohiko Miyazaki, Koichi Yasuda, Hiroshi Taguchi, et al.
Journal of Applied Clinical Medical Physics|December 31, 2019
Analysis of treatment process time for real-time-image gated-spot-scanning proton-beam therapy (RGPT) systemTakaaki Yoshimura, Shinichi Shimizu, Takayuki Hashimoto, et al.
Biochemical and Biophysical Research Communications|February 5, 2022
The function of SARS-CoV-2 spike protein is impaired by disulfide-bond disruption with mutation at cysteine-488 and by thiol-reactive N-acetyl-cysteine and glutathioneMana Murae, Yoshimi Shimizu, Yuichiro Yamamoto, et al.
Plos One|May 17, 2017
Safety and efficacy of cell-free and concentrated ascites reinfusion therapy (CART) in refractory ascites: Post-marketing surveillance resultsNorio Hanafusa, Ayako Isoai, Tomoaki Ishihara, et al.
Lung Cancer (Amsterdam, Netherlands)|July 24, 2018
Stereotactic body radiotherapy to treat small lung lesions clinically diagnosed as primary lung cancer by radiological examination: A prospective observational studyTetsuya Inoue, Norio Katoh, Yoichi M Ito, et al.
Anticancer Research|January 2, 2020
Pulmonary Oligometastases Treated by Stereotactic Body Radiation Therapy: A Nationwide Survey of 1,378 PatientsYuzuru Niibe, Takaya Yamamoto, Hiroshi Onishi, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Iscience|March 19, 2024
Overcoming antibody-resistant SARS-CoV-2 variants with bispecific antibodies constructed using non-neutralizing antibodiesTetsuya Inoue, Yuichiro Yamamoto, Kaoru Sato, et al.
EJNMMI Research|December 6, 2019
Combination of FDG-PET and FMISO-PET as a treatment strategy for patients undergoing early-stage NSCLC stereotactic radiotherapyShiro Watanabe, Tetsuya Inoue, Shozo Okamoto, et al.
Journal of Radiation Research|May 14, 2026
Optimal combination of heart and lung dose parameters in radiotherapy for locally advanced non-small cell lung carcinoma: a multicenter retrospective studyTomohiko Miyazaki, Koichi Yasuda, Hiroshi Taguchi, et al.
Journal of Applied Clinical Medical Physics|December 31, 2019
Analysis of treatment process time for real-time-image gated-spot-scanning proton-beam therapy (RGPT) systemTakaaki Yoshimura, Shinichi Shimizu, Takayuki Hashimoto, et al.
Biochemical and Biophysical Research Communications|February 5, 2022
The function of SARS-CoV-2 spike protein is impaired by disulfide-bond disruption with mutation at cysteine-488 and by thiol-reactive N-acetyl-cysteine and glutathioneMana Murae, Yoshimi Shimizu, Yuichiro Yamamoto, et al.
Plos One|May 17, 2017
Safety and efficacy of cell-free and concentrated ascites reinfusion therapy (CART) in refractory ascites: Post-marketing surveillance resultsNorio Hanafusa, Ayako Isoai, Tomoaki Ishihara, et al.
Lung Cancer (Amsterdam, Netherlands)|July 24, 2018
Stereotactic body radiotherapy to treat small lung lesions clinically diagnosed as primary lung cancer by radiological examination: A prospective observational studyTetsuya Inoue, Norio Katoh, Yoichi M Ito, et al.
Anticancer Research|January 2, 2020
Pulmonary Oligometastases Treated by Stereotactic Body Radiation Therapy: A Nationwide Survey of 1,378 PatientsYuzuru Niibe, Takaya Yamamoto, Hiroshi Onishi, et al.
Pageof 5